India must save the reputation of its pharma industry

It’s now been a year since a ‘Made in India’ cough syrup was linked to the deaths of more than 70 children in the West African country of Gambia. Since that tragedy, several accusations have emerged from around the world, ranging from Uzbekistan to the United States, from Sri Lanka to Cameroon. Each of these countries has accused ‘Made in India’ drugs of causing death, blindness and serious injuries to their citizens.

Separate and apart from these tragedies in foreign jurisdictions is the fact that Indian doctors protested against a new rule introduced by the National Medical Commission (NMC) that requires all doctors to write prescriptions using only the generic names of drugs and no brand names. The reason for

Disclaimer: These are personal views of the writer. They do not necessarily reflect the views of www.business-standard.com or the Business Standard newspaper

First print: November 16, 2023 | 12:07 pm IST

Related Post